Ori Biotech raises over USD 100 million in Series B funding to launch innovative cell and gene therapy manufacturing platform Funds will allow for a rapid transition through pre-commercialization to market launch London, UK, January 18, 2022 – Read More
Current Health – the leading enterprise remote care management platform – today announced it has raised $43M in Series B financing. The round was led by Northpond Ventures, with additional financing from LRVHealth, OSF HealthCare, Section 32, Elements Read More
Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing Syndicate led by leading life science investors Northpond Ventures alongside Octopus Ventures October 14, 2020, London, UK and Woodcliff Read More
This will close in 25 seconds
